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Cyclopamines) are the progenitors of reproductive cells in metazoans and are an important
model for the study of cell migration in vivo. Previous reports have suggested that Hedgehog (Hh) protein
acts as a chemoattractant for PGC migration in the Drosophila embryo and that downstream signaling
proteins such as Patched (Ptc) and Smoothened (Smo) are required for PGC localization to somatic gonadal
precursors. Here we interrogate whether Hh signaling is required for PGC migration in vertebrates, using the
zebraﬁsh as a model system. We ﬁnd that cyclopamine, an inhibitor of Hh signaling, causes strong defects in
the migration of PGCs in the zebraﬁsh embryo. However, these defects are not due to inhibition of
Smoothened (Smo) by cyclopamine; rather, we ﬁnd that neither maternal nor zygotic Smo is required for
PGC migration in the zebraﬁsh embryo. Cyclopamine instead acts independently of Smo to decrease the
motility of zebraﬁsh PGCs, in part by dysregulating cell adhesion and uncoupling cell polarization and
translocation. These results demonstrate that Hh signaling is not required for zebraﬁsh PGC migration, and
underscore the importance of regulated cell–cell adhesion for cell migration in vivo.
© 2009 Elsevier Inc. All rights reserved.Introduction
In metazoans, germline tissue is required for the transmission of
genetic information from one generation to the next. Consistent with
the importance of this function, many behaviors of early germline
tissue are conserved across species. Primordial germ cells (PGCs),
progenitors of the germline lineage, are typically speciﬁed in locations
distal to the future gonad ﬁeld and thereforemust migrate extensively
through somatic tissues during embryogenesis. Once PGCs arrive at the
presumptive gonad site, they associate with somatic precursors of the
reproductive organs and ultimately differentiate into sperm or ova.
The molecular mechanisms that regulate germ cell speciﬁcation,
migration, and differentiation are not completely understood, but
studies of Drosophila and zebraﬁsh have provided key insights into
invertebrate and vertebrate PGC development, respectively (Kunwar
et al., 2006; Raz, 2003). In fruitﬂies, PGCs are initially speciﬁed by
maternally derived mRNAs and other germ plasm components that
are localized to the posterior end of the early embryo (Lehmann and
Nusslein-Volhard, 1986). During gastrulation, the Drosophila PGCs are.
l rights reserved.carried with associated somatic cells to the posterior midgut, after
which they traverse themidgut epithelium and attach to the overlying
mesoderm (Warrior, 1994). The PGCs then migrate bilaterally toward
clusters of somatic gonadal precursor cells, with which they coalesce
to form the gonad (Boyle et al., 1997). Zebraﬁsh PGCs are similarly
speciﬁed by maternal germ plasm determinants, in this case localized
to the cleavage planes at the two- and four-cell stages (Weidinger et
al., 1999). By the 1000-cell stage (3 h post fertilization (hpf)), the
zebraﬁsh embryo contains four PGCs in a square-like conﬁguration
that is randomly oriented with respect to the dorsal–ventral axis. The
PGCs then begin to proliferate, and between 4 and 5 hpf they
transition from round, immotile cells into a polarized migratory
population (Blaser et al., 2005), localizing to the anterior and lateral
boundaries of the mesoderm during gastrulation (Weidinger et al.,
1999). The PGCs continue to migrate toward an intermediate region
bordering the mesoderm during somitogenesis, until 25 to 50 cells are
bilaterally restricted to the anterior end of the yolk extension
(between the eighth and tenth somites) at 24 hpf.
The long-range migration undertaken by PGCs has garnered
particular interest not only as an integral step in gonad development,
but also as model system for the study of directed cell movements in
vivo. Previous studies have revealed several factors that are necessary
for both PGC migration and survival. For example, germ plasm in
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mRNAs, including vasa (Hay et al., 1988; Yoon et al., 1997) and nanos
(Koprunner et al., 2001; Wang and Lehmann, 1991), and embryos
lacking these transcripts or the proteins they encode exhibit
mislocalized PGCs that are ultimately lost. In fruitﬂies, PGC motility
and maintenance is further regulated by lipid phosphate phospha-
tases encoded by the wunen genes, which appear to produce a
repellent signal (Renault et al., 2004). Zebraﬁsh PGC development is
also regulated by the dead end (dnd) gene, which is essential for PGC
migration and survival (Weidinger et al., 2003).
A second class of factors is required for PGC migration but not
survival, regulating either the basicmotility of these progenitor cells or
their chemotaxis. For instance, zebraﬁsh PGCs deﬁcient for phospha-
tidylinositol 3-kinase (PI3K) signaling have reduced speed but
maintain their capacity for directed migration (Dumstrei et al.,
2004). Similarly, E-cadherin is downregulated in zebraﬁsh PGCs as
they begin to migrate, and its aberrant upregulation reduces PGC
migration speed but not directionality (Blaser et al., 2005). Other genes
are required for the chemotaxis of PGCs but not their general motility.
Such factors include the zebraﬁsh chemoattractant stromal-derived
factor 1a (sdf1a) (Doitsidou et al., 2002) and its receptor cxcr4b (Knaut
et al., 2003). PGC chemotaxis in both Drosophila and zebraﬁsh also
requires the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reduc-
tase (HMG-CoAR). In fruitﬂies, HMG-CoAR is selectively expressed in
somatic gonadal precursor cells during the second phase of PGC
migration, and loss of this gene in columbus mutants results in PGC
mislocalization (Van Doren et al., 1998). Conversely, cells ectopically
expressing HMG-CoAR can attract migratory PGCs. Since this enzyme
is the rate-limiting step in the mevalonate pathway, which is
speciﬁcally utilized in fruitﬂies to synthesize isoprenoids, it has been
hypothesized that an isoprenylated protein is required for PGC
attraction (Santos and Lehmann, 2004). Consistent with this model,
mislocalized PGCs are observed in Drosophila lacking farnesyl-dipho-
sphate synthase, geranylgeranyl diphosphate synthase, or geranylger-
anyl transferase 1, three enzymes that act downstream of HMG-CoAR
in the biosynthesis of geranylgeranylated proteins, and ectopic
expression of either synthase gene is sufﬁcient to induce fruitﬂy PGC
chemotaxis (Santos and Lehmann, 2004). A conserved regulatory
mechanism may also operate in zebraﬁsh, as embryos treated with
pharmacological inhibitors of either HMG-CoAR or geranylgeranyl
transferase 1 exhibit germ cell migration defects (Thorpe et al., 2004).
Other studies have implicated the Hedgehog (Hh) pathway as a
regulator of PGC migration in fruitﬂies. Drosophila Hh signaling is
initiated by the secreted Hh ligand, which acts through its receptor
Patched (Ptc) and the transmembrane protein Smoothened (Smo) to
activate Hh target gene expression by the Cubitus interruptus (Ci)
transcription factor (Ingham and McMahon, 2001). Hh pathway
activity is also promoted by the serine–threonine kinase Fused (Fu)
and repressed by protein kinase A (PKA). It was ﬁrst reported that
Drosophila embryos lacking maternal ptc, smo, pka, or fu exhibit PGC
migration defects, suggesting that inappropriate Hh pathway upre-
gulation or downregulation disrupts germ cell migration to the
somatic gonadal precursor cells (Deshpande et al., 2001). In addition
to PGC mislocalization, loss of either maternal ptc or pka caused
premature PGC aggregation, perhaps due to precocious acquisition of
a developmental signal that is normally produced by the presumptive
gonad. Since hh reporter activity was also observed in somatic gonadal
precursor cells and ectopic hh expression could partially re-direct PGC
migration, it was hypothesized that the Hh protein acts as a PGC
chemoattractant, possibly through the activation of downstream
signaling components (Deshpande et al., 2001).
More recently it has been proposed that HMG-CoAR regulates
Drosophila PGC migration by potentiating the release of Hh protein
from somatic gonadal precursor cells (Deshpande and Schedl, 2005),
perhaps by promoting geranylation of the G protein submit Gγ1
(Deshpande et al., 2009). Embryos lacking zygotic HMG-CoAR or Gγ1activity exhibit signiﬁcantly reducedHh proteinmovement, andHMG-
CoAR overexpression in Hh-producing cells causes an expansion of the
Hh ligand distribution. These perturbations also induced changes in
Smo localization and expression of the Hh target genewingless that are
consistent with HMG-CoAR- and Gγ1-dependent release of active Hh
ligand. Consistent with the Hh chemoattractant model, it has further
been observed that fruitﬂies lacking tout-velu (ttv), a critical regulator
of heparan sulfate proteoglycan biosynthesis and Hh protein move-
ment, exhibit PGC migration defects (Deshpande et al., 2007).
Whether Hh ligands serve a similar chemoattractant role in other
organisms is not known. Cellular and molecular similarities between
germ cell ontogeny in Drosophila and zebraﬁsh suggest that the latter
organismwould be an ideal model system for investigating a possible
role for Hh signaling in vertebrate PGCmigration.We therefore sought
to determine whether Hh signaling is required for PGC migration in
zebraﬁsh, using both pharmacological and genetic perturbations of
this developmental pathway. Our studies exploit the amenability of
zebraﬁsh embryos to genetic manipulations, chemical perturbations,
and optical imaging, which provides an opportunity to analyze
vertebrate PGC migration in real-time and with subcellular resolution
(Raz, 2003). Here we report that cyclopamine, an inhibitor of Hh
signaling that directly targets Smo, elicits a strong defect in PGC
motility. This chemical perturbation involves both germline and
somatic cell lineages, but does not affect PGC chemotaxis or
maturation. Cyclopamine, however, exerts these effects through
Smo-independent mechanisms, including dysregulation of PGC cell
adhesion. In contrast to previous observations in Drosophila, zebraﬁsh
embryos lacking both maternal and zygotic Smo exhibit normal PGC
migration, indicating that Hh proteins do not act as a PGC
chemoattractant in this system. Our studies also raise the possibility
that other organismal and cellular phenotypes associated with
cyclopamine treatment may involve Hh pathway-independent
mechanisms of action.
Materials and methods
Zebraﬁsh strains and ﬁsh maintenance
Zebraﬁsh (Danio rerio) of the wildtype AB genetic background and
strains heterozygous for mutant alleles of smo (smuhi1640 and
smub577), sonic hedgehog (syutbx392), gli1 (dtrts269), gli2a (yotty119), or
dispatched1 (contm15a) were obtained from either the Zebraﬁsh
International Resource Center, the Tübingen Zebraﬁsh Stock Center,
or individual laboratories. Tg(kop:EGFP-F-nanos1-3′UTR) zebraﬁsh,
which selectively express farnesylated, enhanced GFP in PGCs, have
been previously described (Blaser et al., 2006). All zebraﬁsh strains
were maintained, raised, and staged according to standard protocols
(Kimmel et al., 1995; Westerﬁeld, 1995). Embryos were obtained by
natural matings and cultured at 28 °C unless otherwise noted.
Cyclopamine treatment of zebraﬁsh embryos
Cyclopamine treatments were initiated at the one-cell stage with a
100 μM solution in E3 medium (Nusslein-Volhard and Dahm, 2002)
unless otherwise noted. All cyclopamine-containingmediaweremade
from a stock solution in ethanol, such that the ﬁnal ethanol
concentration was 0.2% (v/v). An equivalent amount of ethanol in
E3 mediumwas used a vehicle control. Time course experiments were
performed by culturing embryos in ethanol-containing E3 medium
until the indicated time points, after which they were transferred into
medium containing 100 μM cyclopamine. Cyclopamine washout
experiments were conducted by incubating the embryos in cyclopa-
mine-containing E3 medium and washing them extensively (at least
three times) with ethanol-containing E3 medium at end of each
treatment regimen. The embryos were then cultured further in
ethanol-containing E3 medium.
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One- and two-color whole-mount in situ hybridization protocols
were performed as described previously (Hauptmann and Gerster,
1994; Jowett and Lettice, 1994). The following digoxigenin-labeled
probes were used: vasa (Olsen et al., 1997; Yoon et al., 1997), nanos1
(Koprunner et al., 2001), sdf1a (Doitsidou et al., 2002), and ziwi
(Houwing et al., 2007). The vasa probe was used to label PGCs, which
were scored according to their location within or outside of the
presumptive gonad site in the lateral plate mesoderm. At least 400
PGCs (approximately 15 embryos) were typically scored to determine
the percentage of mislocalized cells.
Whole-mount immunostaining of zebraﬁsh embryos was per-
formed according to standard protocols (Macdonald, 1999; Nusslein-
Volhard and Dahm, 2002) using the following primary antibodies:
rabbit polyclonal anti-Vasa (Knaut et al., 2000) (1:5000 dilution),
rabbit polyclonal anti-green ﬂuorescent protein (GFP) (Invitrogen/
Molecular Probes, 1:500 dilution), mousemonoclonal anti-E-cadherin
(clone 36, BD Biosciences; 1:500 dilution), mouse monoclonal anti-β-
actin antibody (clone AC-15, Sigma; 1:1000 dilution), and mouse
monoclonal anti-α-tubulin (clone DM1a, Sigma; 1:500 dilution).
Alexa Fluor 488- and Alexa Fluor 594-conjugated secondary anti-
bodies (Invitrogen/Molecular Probes) were used at a 1:1000 dilution.
RNA expression and morpholino knockdown experiments
Capped sense RNA for the following constructs was synthesized
with the MessageMachine kit (Ambion) and microinjected into one-
cell stage embryos: sdf1a-globin-3′UTR (Doitsidou et al., 2002), EGFP-
nanos1-3′UTR (Koprunner et al., 2001), and vasa-dsRedex-nanos1-3′
UTR (Strasser et al., 2008). The nanos1-3′UTR sequence was used to
direct protein expression to the PGCs.
Antisensemorpholinos (Gene-Tools) targeting the following genes
were microinjected into one-cell stage embryos: sdf1a (5-CTACTAC-
GATCACTTTGAGATCCAT-3′) (Doitsidou et al., 2002), sdf1b (5′-
TTGCTATCCATGCCAAGAGCGAGTG-3′) (Boldajipour et al., 2008), E-
cadherin (5′-AAAGTCTTACCTGAAAAAGAAAAAC-3′) (Shimizu et al.,
2005), E-cadherin ﬁve-base mismatch (5′-AAACTCATACGTGAAAAA-
CAAATAC-3′), and smo (5′-CGCTTGGAGGACATCTTGGAGACGC-3′)
(Robu et al., 2007).
Determination of zebraﬁsh Smo sensitivity to cyclopamine
Zebraﬁsh Smo cDNAwas subcloned into the pCS105 vector through
ClaI and NheI sites using the PCR primers 5′-TATATAAGCTTATCGATC-
CACCATGTCCTCCAAGCGCCCT-3′ and 5′-AAGCTAGCGAAAAATCTGAGT-
CAGCATCCAATAGCT-3′. Smo−/−murine embryonic ﬁbroblasts (MEFs)
(Ma et al., 2002) were cultured in DMEM containing 10% fetal bovine
serum (FBS) to approximately 50% conﬂuency and then co-transfected
with the zebraﬁsh Smo expression construct, a Gli-dependent ﬁreﬂy
luciferase reporter (Sasaki et al., 1997), and a constitutive Renilla
luciferase reporter (pRLSV40, Promega) using Fugene 6 transfection
reagent (Roche) according to the manufacturer's protocols. After two
days, the cells were cultured in DMEM containing 0.5% FBS, the N-
terminal domain of Sonic Hedgehog protein (Shh-N) (Chen et al.,
2002b), and various concentrations of cyclopamine for an additional
30 h. Fireﬂy and Renilla luciferase activities in the Smo−/−MEFs were
then determined using a dual luciferase kit (Promega) according to the
manufacturer's protocols.
Cell transplantation experiments
Donor embryos were prepared by injecting them at the one-cell
stage with Alexa Fluor 594-dextran (1.8 ng/embryo; 10,000 MW,
Invitrogen/Molecular Probes) and EGFP-nanos1-3′UTR mRNA
(200 pg/embryo) (Koprunner et al., 2001). Donor and host embryoswere then cultured in E3 medium containing either 100 μM
cyclopamine or an ethanol vehicle control as appropriate. Donor and
host embryos were raised at 28 °C and 24 °C, respectively, so that they
would reach the proper stages for transplantation at the same time.
Just prior to cell harvesting and transplantation, the embryos were
dechorionated with pronase and then washed extensively with E2
medium (Nusslein-Volhard and Dahm, 2002).
Transplantations were performed in E2 medium using an
Eppendorf CellTram Vario. Needles were made from 1.0-mm glass
capillaries pulled on a Sutter P-87 pipette puller, and their tips were
broken manually with forceps. During transplantation, PGCs were
visualized by EGFP ﬂuorescence with a Leica MZFLIII stereoscope, and
one to three PGCs were removed from shield-stage donor embryos
with as little surrounding tissue as possible (usually 10 to 25 cells).
This tissue was then implanted into the margin of sphere-stage host
embryos. The host embryos were cultured further in cyclopamine-free
E3 medium to 24 hpf, and PGCs were visualized by EGFP ﬂuorescence.
Transplanted PGCs were scored according to their location within or
outside of the presumptive gonad, deﬁned to be lateral plate
mesoderm between the eighth and tenth somites.
PGC chemotaxis assay
PGC directed migration was assessed as previously described
(Blaser et al., 2005). Donor embryos fromwildtype AB adult zebraﬁsh
were microinjected at the one-cell stage with sdf1a MO (0.4 pmol/
embryo), sdf1b MO (0.4 pmol/embryo), Alexa Fluor 568-dextran
(150 pg/embryo; 10,000 MW, Invitrogen/Molecular Probes), and
synthetic MO-resistant sdf1a-globin-3′UTR mRNA (240 pg/embryo).
Tg(kop:EGFP-F-nanos1-3′UTR) host embryos were microinjected at
the one-cell stage with the sdf1a and sdf1bMOs and then treated with
100 μM cyclopamine or an ethanol control until the transplantation
procedure.
Somatic cells were harvested from donor embryos at 30% epiboly
(5 hpf) and transplanted into host embryos at 50% epiboly (5.5 hpf).
The host embryos were then maintained in cyclopamine-containing
medium and imaged by time-lapse ﬂuorescence microscopy (6 to
7 hpf).
Time-lapse imaging and image quantiﬁcation
Time-lapse imaging of PGC migration in Tg(kop:EGFP-F-nanos1-3′
UTR) embryos was performed using an upright Leica DM4500B
compound microscope equipped with a narrow-pass GFP ﬁlterset, a
10X objective, and a deep-cooled, charge-coupled device camera
(Retiga SRV) controlled by ImagePro software (MediaCybernetics).
Tg(kop:EGFP-F-nanos1-3′UTR) embryos were immobilized in an
agarose template during late gastrulation and early segmentation
(8 to 12 hpf), and PGCs in the dorsolateral region were imaged at a
rate of one frame/min for at least 120 min with manual refocusing as
necessary. Cyclopamine-treated embryos were cultured in drug-
containing E3 medium throughout each time-lapse experiment.
Embryos cultured in E3 medium containing the ethanol vehicle alone
were imaged as controls.
PGCs from the image stacks were tracked manually in ImagePro,
with three tracks generated for each cell to minimize user error. In
addition, morphological features in the unlabeled somatic tissue were
tracked to account for background morphogenetic movements in the
gastrulating embryo. Approximating the zebraﬁsh embryo as a two-
dimensional plane, tracks were then exported as coordinate data.
Somatic tissue coordinate data were subtracted from the PGC
coordinate data to correct for background movements, and PGC
migration speeds were averaged over three consecutive frames. To
quantify the directed migration of individual PGCs, the uncorrected
PGC coordinate data were used to calculate the change in angle
trajectory between frames. Angle changes were then averaged among
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angle change for the PGC at the center frame.
Individual PGCs were assigned a morphology state of either
“elongated” or “round,” and a phase state of “run” or “tumble” for each
frame (Reichman-Fried et al., 2004). The runphase for these studieswas
deﬁned to be a motile state with an elongated cellular morphology.
Adhesive interactions between germ cells were also recorded, using the
plasma membrane-localized green ﬂuorescence in Tg(kop:EGFP-F-
nanos1-3′UTR) PGCs to identify regions of cell–cell contact.
Generation of MZsmuhi1640 zebraﬁsh embryos
Maternal-zygotic mutant zebraﬁsh were generated by germline
replacement as previously described (Ciruna et al., 2002). To create
MZsmuhi1640 zebraﬁsh, progeny from intercrosses of smuhi1640 hetero-
zygotes were injected with EGFP-nanos1-3′UTR mRNA (200 pg/
embryo) and then used at the sphere stage as donor for transplanta-
tion into sphere-stage wildtype hosts. About 100 to 200 cells were
transplanted into each host, and successful transplants were scored at
24 hpf by the presence of EGFP ﬂuorescence at the presumptive gonad
site (typically 15–25% of the transplanted hosts). The chimera were
then raised to adulthood and mated to smuhi1640 heterozygotes to
ascertain gamete genotype. One female bearing smuhi1640 oocytes and
four males bearing smuhi1640 sperm were isolated from 69 chimeric
adults.
To create MZsmub577 zebraﬁsh, donor embryos were generated by
intercrosses of smub577 heterozygotes, and wildtype embryos were
used as hosts (Thomas et al., 2008). The donor embryos were injected
with EGFP-nanos1-3′UTR mRNA, and at 24 hpf the host embryos were
screened for the presence of donor-derived, EGFP-expressing PGCs.
The genotype of the corresponding donor embryo for each host was
determined phenotypically at this stage. Three females bearing
smub577 oocytes and six males bearing smub577 sperm were success-
fully isolated from 67 chimeric adults.
Both MZsmuhi1640 and MZsmub577 embryos exhibit morphological
phenotypes similar to those observed in zygotic smumutants, including
U-shaped somites, ventral body curvature, and circulation defects.
Western blot analyses
To conduct western blot analyses of E-cadherin expression,
zebraﬁsh embryos (6 or 24 hpf) were manually dechorionated and
dissociated in ice-cold buffer (5 mM HEPES, pH 7.0, 100 mM NaCl,
5 mM KCl, 1% (w/v) PEG-20,000) containing a protease inhibitor
mixture (Roche) and 1 mM phenylmethanesulfonylﬂuoride. The
dissociated cells were then collected by centrifugation (300 g, 4 °C)
and disrupted in sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis loading buffer with sonication. The resulting cellular lysates
were then separated by gel electrophoresis and transferred to
polyvinylidene ﬂuoride membranes. At least 20 embryos were used
for each experimental condition, with lysate obtained from approxi-
mately ﬁve embryos analyzed in each gel electrophoresis lane. E-
cadherin immunoblotting was conducted by chemiluminescence
detection (Pierce, SuperSignal West Pico), using either a mouse
monoclonal anti-E-cadherin antibody (clone 36, BD Biosciences;
1:5000 dilution) or a rabbit polyclonal anti-E-cadherin (1:10,000
dilution) (Babb andMarrs, 2004).Western blot analyses of actin levels
were performed as loading control, using a mouse monoclonal anti-β-
actin antibody (clone AC-15, Sigma; 1:10,000 dilution).
Results
Cyclopamine induces PGC mislocalization in zebraﬁsh embryos
Since previous studies have implicated the Hh ligand and its
downstream effectors as regulators of Drosophila PGC migration(Deshpande and Schedl, 2005; Deshpande et al., 2007, 2001), we
sought to investigate whether Hh pathway components are required
for PGC migration in vertebrates. We focused on zebraﬁsh PGCs as a
model system, since the genetic tractability, pharmacological sensi-
tivity, and optical transparency of zebraﬁsh embryos have made them
ideally suited for analyzing germline development (Raz, 2003). In
addition, a number of Hh signaling proteins in zebraﬁsh have been
cloned, and their expression patterns during embryogenesis have
been analyzed. For example, the essential Hh signal transducer smo is
provided maternally, uniformly transcribed during gastrulation, and
then preferentially expressed in anterior tissues by 24 hpf (Chen et al.,
2001; Varga et al., 2001).
We ﬁrst treated zebraﬁsh embryos with cyclopamine, a small-
molecule inhibitor of Hh signaling that directly inhibits Smo (Chen et
al., 2002a). We found that continuous exposure to 100 μM cyclopa-
mine starting at the one-cell stage caused PGC mislocalization
throughout the embryos by 24 hpf, as determined by the distribution
of vasa-positive cells (Figs. 1A, B). Treatment of zebraﬁsh embryos
with simpler organic amines such as piperidine and diethylamine at
identical concentrations did not yield this PGC phenotype (data not
shown), conﬁrming that the cyclopamine-dependent PGC mislocali-
zation is dependent upon its speciﬁc three-dimensional structure and
not due to it basicity. The degree of PGC mislocalization at the highest
doses of cyclopamine is at least comparable to that observed with the
statins, pharmacological inhibitors of HMG-CoAR that perturb PGC
migration in zebraﬁsh (Thorpe et al., 2004).
We next analyzed the dose-dependence of cyclopamine action on
PGC localization. We observed that this teratogen has a median
effective concentration (EC50) of approximately 30 μM, with the
percentage of mislocalized PGCs reaching a plateau by 100 μM
concentrations (Fig. 1C). This activity proﬁle is similar to that reported
for cyclopamine-dependent Hh pathway inhibition in zebraﬁsh as
measured by ptc1 transcript levels (Wolff et al., 2003). Since
cyclopamine has a median inhibitory concentration (IC50) of 300 nM
toward Hh pathway activation in murine cell lines (Taipale et al.,
2000), this antagonist could be either less potent against zebraﬁsh
Smo than mouse Smo or less able to penetrate zebraﬁsh embryos than
cultured cells. To distinguish between these two possibilities, we
assessed the ability of cyclopamine to inhibit zebraﬁsh Smo in
cultured cells. Embryonic ﬁbroblasts derived from Smo−/− mice
were transiently transfected with zebraﬁsh smo, which restores the
ability of these cells to activate Hh target gene expression in response
to Shh-N-conditionedmedium. As determined by a co-transfected Gli-
dependent ﬁreﬂy luciferase reporter, cyclopamine was very potent at
inhibiting zebraﬁsh Smo-mediated Shh signaling, with an IC50 of
approximately 15 nM (Fig. 1D). Since cyclopamine should exhibit a
similar activity against zebraﬁsh Smo in vivo, we conclude that the
embryonic concentration of cyclopamine is also nanomolar when
drug concentrations in the culture medium are in the micromolar
range. This 1000-fold difference in cyclopamine concentration is likely
due to poor tissue penetrance or rapid efﬂux from the embryo.
Cyclopamine perturbs the earliest stages of PGC migration
In principle, cyclopamine could disrupt the targeting of zebraﬁsh
PGCs to the presumptive gonad at any point during the ﬁrst 24 h of
germ cell development. Speciﬁed by maternally provided determi-
nants, zebraﬁsh PGCs are initially round, immotile cells. Between 4
and 5 hpf, they exhibit a polarized morphology and extend
protrusions in a stochastic manner, until they begin to migrate
actively toward regions of sdf1a expression in the developing embryo.
This migratory phase continues during gastrulation and somitogen-
esis, with the PGCs reaching the presumptive gonad by 24 hpf (Blaser
et al., 2005; Weidinger et al., 1999). To deﬁne the temporal window
during which cyclopamine affects PGC localization, we varied the
developmental stages at which we initiated exposure to this
Fig. 1. Cyclopamine treatment induces zebraﬁsh PGC mislocalization. (A, B) PGCs localize to the presumptive gonad in the ethanol-treated control embryos, as indicated by the
distribution of vasa-expressing cells. In contrast, PGCs are widely dispersed in embryos treated with 60 μM cyclopamine. Cyclopamine and ethanol treatments were initiated at the
one-cell stage and the resulting phenotypes at 24 hpf are shown. Scale bar: 200 μm. (C) Dose–response proﬁle for cyclopamine-induced PGC mislocalization. At least 400 PGCs were
scored at 24 hpf for each cyclopamine concentration. (D) Dose–response proﬁle for cyclopamine inhibition of Shh signaling in Smo−/−mouse embryonic ﬁbroblasts transfected with
zebraﬁsh smo. Data are the average of triplicate samples, with error bars representing the standard deviations. (E) Temporal window of cyclopamine action with respect to PGC
mislocalization, as determined by a survey of treatment regimens. At least 500 PGCs were scored at 24 hpf for each time course of cyclopamine exposure.
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gastrulation, as gauged by the resulting distribution of vasa-positive
cells at 24 hpf (Fig. 1E). Treatment with cyclopamine had its strongest
effects when initiated by 2 hpf, and compound administration after
6 hpf had little effect on the localization of these progenitor cells, even
though the bulk of PGC migration to the presumptive gonad site
occurs during this time.
We also performed complementary experiments in which cyclo-
pamine was added to one-cell stage embryos and then washed out a
different time points. The effects of these treatments on PGC
localization at 24 hpf was assayed, and cyclopamine treatment from
0 to 6 hpf was required for the strongest degree of PGC mislocaliza-
tion. Teratogen exposure from 0 to 3 hpf only had a small effect on PGC
targeting to the presumptive gonad. Taken together, these data
indicate that the critical time window for cyclopamine-induced PGC
mislocalization is between 3 and 6 hpf, a time during which PGCs are
only beginning their migration toward sdf1a-expressing somatic
tissues.Cyclopamine acts on both PGCs and somatic tissues
Since cyclopamine acts early during PGC development to perturb
cell migration, we investigated whether its effects were cell-
autonomous with respect to these progenitor cells. We performed
cell transplantation studies in which we transferred PGCs with as few
somatic cells as possible from shield-stage (6 hpf) donor embryos to
sphere-stage (4 hpf) hosts (Fig. 2A). This transplantation regimen
allowed us to analyze PGC function after the critical time window for
cyclopamine action has passed (3 to 6 hpf).
The donor embryos were injected with Alexa Fluor 594-dextran to
provide a red ﬂuorescent marker for all donor cells and EGFP-nanos1-
3′UTR mRNA to selectively label the PGCs with green ﬂuorescence.
After transplantation, the donor-derived cells are widely distributed
such that the PGCs are almost exclusively in contact with host tissue
(Supplementary Movie 1). Using EGFP ﬂuorescence we then scored
the locations of donor PGCs in the host embryo at 24 hpf. When the
donor and host embryos were both treated with an ethanol vehicle
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tion in response to the transplantation regimen alone (Figs. 2B and B′).
As expected, the extent of PGC mislocalization signiﬁcantly increased
when both donor and host embryos were treated with cyclopamine
prior to transplantation (Figs. 2C and C′).
Using this system, we could then determine whether cyclopamine
exerts its effects on the PGCs, somatic tissues, or both, by adminis-
tering cyclopamine to only the donor or host embryos. When only the
donor embryowas treatedwith cyclopamine, we observed amoderate
increase in PGC mislocalization over basal levels (Figs. 2D and D′).
However, when the host embryowas treated with cyclopamine before
transplantation, a greater fraction of PGCs failed to reach the
presumptive gonad site (Figs. 2E and E′). Quantitative analyses of
these data conﬁrm that cyclopamine acts primarily through the soma
to perturb PGC migration (Fig. 2F), although the teratogen directly
impairs the progenitor cells to some extent. This mechanism of action
does not appear to involve sdf1a, which acts as a PGC chemoattractant
(Doitsidou et al., 2002), since cyclopamine does not signiﬁcantly alter
sdf1a expression during gastrulation or somitogenesis (Figs. 2G–L).
Cyclopamine perturbs PGC motility rather than chemotaxis
To further investigate the mechanism by which cyclopamine
causes PGC mislocalization, we used time-lapse imaging to study PGC
migration in Tg(kop:EGFP-F-nanos1-3′UTR) embryos, which harbor a
transgene that selectively expresses farnesylated EGFP in these cells
(Blaser et al., 2005). We observed the migration of PGCs during late
gastrulation and early segmentation (8 to 12 hpf), since cyclopamine-
treated PGCs ﬁrst digress from sdf1a-expressing tissues at these stages
(Supplementary Fig. 1). In embryos treated with an ethanol vehicle
control, the PGCs migrated independently (Supplementary Movie 2),
following long trajectories that often circled back upon themselves but
traveled signiﬁcant distances from the origin (Fig. 3A). In contrast,
embryos continuously treated with cyclopamine starting at the one-
cell stage had PGCs that exhibited slower motility and adhered to each
other frequently (Supplementary Movie 3). The cyclopamine-treated
PGCs also followed short trajectories that did not extend far from the
origin (Fig. 3A).
Zebraﬁsh PGCs undergo a series of alternating phases in their
migration, which have been denoted “running” and “tumbling” in
analogy to bacterial movement (Reichman-Fried et al., 2004). Run
phases are characterized by cell elongation and polarization, as well as
a burst of motion along the vector of cell polarity. In contrast, tumble
phases intersperse run phases and are characterized by rapidly
changing polarization vectors with minimal overall migration. Each
phase persists for a few minutes.
To study the migratory behavior of cyclopamine-treated PGCs
more closely, we analyzed PGC speed, directionality, and morphol-
ogy in embryos exposed to the teratogen or an ethanol vehicle
control (Fig. 3B). Continuous treatment with cyclopamine beginning
at the one-cell stage not only diminished PGC speed (Fig. 3C), but
also reduced the fraction of time spent in run phases (Fig. 3D).
Interestingly, cyclopamine did not change the fraction of time PGCs
exhibit an elongated, polarized morphology (Fig. 3D), which is
nearly always associated with the run phase in wildtype embryos
(see Fig. 3B). These seemingly contradictory observations can be
reconciled if cyclopamine decouples cell polarization and transloca-
tion, and consistent with this model, the cyclopamine-treated PGCs
were often immotile even when they were elongated and polarized.
The average duration of these abnormal polarized phases was
greater than that of polarized phases in ethanol-treated embryos
(Fig. 3E), but the frequency with which cyclopamine-treated
embryos switched between non-polarized and polarized morphol-
ogies was reduced in comparison to control cells (Fig. 3F and
Supplementary Movies 4 and 5). Collectively, these migration defects
resulted in an overall decrease in cell motility.In addition to characterizing the PGC motility defect, we used real-
time imaging of their migration to verify the temporal window of
action of this teratogen. When embryos were exposed to cyclopamine
from 0 to 6 hpf, their PGCs exhibited movement defects during late
gastrulation that were similar to those of PGCs treated with this
steroid alkaloid throughout embryogenesis (data not shown). How-
ever, PGCs migrated normally in embryos treated with cyclopamine
from 6 hpf onward (data not shown). These combined results conﬁrm
that cyclopamine action prior to 6 hpf is required for its effects on PGC
migration.
To determinewhether PGC chemotaxis is inhibited by cyclopamine
in addition tomotility, we observed the ability of cyclopamine-treated
PGCs to respond to transplanted tissue overexpressing the chemoat-
tractant sdf1a (Doitsidou et al., 2002). PGCs treated with either
cyclopamine or an ethanol vehicle control were able to migrate short
distances to the transplanted source of Sdf1a protein (Fig. 3G and
Supplementary Movies 6 and 7). Thus, the PGC mislocalization
observed in cyclopamine-treated embryos appears to result from
defects in general cell motility rather than a loss of directedmigration.
Cyclopamine does not affect PGC morphology or maturation
Since several genes required for PGC migration are also necessary
for the maintenance of these progenitor cells, we investigated
whether cyclopamine causes any discernible defects in PGC morphol-
ogy or maturation. The prototypical PGC marker genes vasa and na-
nos1 are inherited from maternal stores and expressed in PGCs from
the earliest stages of their speciﬁcation (Koprunner et al., 2001; Olsen
et al., 1997; Yoon et al., 1997). Cyclopamine does not have any effect on
the transcript levels of vasa (see Figs. 1A, B) or nanos1 (Figs. 4A, B),
indicating that cyclopamine-treated PGCs retain their germ plasm-
derived components.
Vasa protein expression provides a later indicator of PGC
development, as this gene is translated soon after PGC fate commit-
ment is established (4 hpf) and is localized to discrete perinuclear
granules (Knaut et al., 2000). Using an antibody raised against
zebraﬁsh Vasa (Knaut et al., 2000), we failed to detect any change in
the expression of endogenous Vasa protein upon cyclopamine
treatment (Figs. 4C, D). The cellular organization of Vasa-containing
perinuclear granules was also not perturbed by this teratogen, as
determined by selectively expressing ﬂuorescently tagged Vasa (Vasa-
dsRedex) in PGCs (Figs. 4E, F). Nor did cyclopamine appear to perturb
PGC maturation, which begins after these cells reach the presumptive
gonad site (24 hpf). One of the earliest known markers of germ cell
maturation is the expression of ziwi, the zebraﬁsh ortholog of the piwi
family of RNA-interacting proteins (Houwing et al., 2007). Even
though PGCs are displaced from the presumptive gonad in cyclopa-
mine-treated embryos, ziwi transcripts can be detected in these cells
by 48 hpf, the same time frame as wildtype PGCs (Figs. 4G, H). In
addition, cyclopamine treatment did not elicit any detectable change
in the number of PGCs throughout their development, indicating that
it does not impede PGC proliferation or survival (Supplementary Fig.
2). These observations indicate that this teratogen does not disrupt
the expression of germ-cell speciﬁc genes in PGCs, the subcellular
organization of these cells, or their maturation. Rather, the effects of
cyclopmine appear to be speciﬁc to PGC motility.
Loss of maternal and zygotic Smo does not recapitulate cyclopamine-
induced defects in PGC migration
Although cyclopamine is widely used as a speciﬁc inhibitor of the
Hh pathway, it is possible that this teratogen inhibits PGC migration
in a Hh pathway-independent manner. We did not observe PGC
defects in mutant embryos lacking zygotic function of Shh (syutbx392)
(Schauerte et al., 1998), Gli1 (dtrts269) (Karlstrom et al., 2003), Gli2a
(yotty119) (Karlstrom et al., 1999), Dispatched1 (contm15a) (Nakano et
348 J.K. Mich et al. / Developmental Biology 328 (2009) 342–354al., 2004), or Smo itself (smuhi1640) (Chen et al., 2001) (Supplemen-
tary Fig. 3). However, the failure to detect PGC defects in these
zygotically mutant embryos could be due to sufﬁcient levels of
maternally supplied factors during the temporal window of
cyclopamine action on PGCs (3 to 6 hpf). For example, maternalsmo transcripts are abundant during early embryogenesis (Chen et
al., 2001; Varga et al., 2001). To address this possibility, we also
assessed PGC localization in zebraﬁsh embryos microinjected with a
MO that targets the translational start site in smo transcripts. PGC
successfully homed to the presumptive gonad site in these embryos,
Fig. 3. Cyclopamine decreases PGC motility without disrupting chemotaxis. (A) Fifteen 100-min tracks of EGFP-expressing PGCs in Tg(kop:EGFP-F-nanos1-3′UTR) embryos treated
with either ethanol or cyclopamine starting at the one-cell stage. PGC migration was followed during late gastrulation and early somitogenesis (8 to 12 hpf); the beginning of each
track is set at the origin and the end of each track is indicated by a black-edged circle. (B) Representative migratory behavior of individual PGCs in ethanol- or cyclopamine-treated
embryos over a similar time frame. Speed and vectoral changes are depicted by the blue and red lines, respectively. Time frames during which the PGCs exhibit an elongated
morphology are indicated by the yellow bars, and run phases are indicated by the green bars. Note that run phases in embryos treated with the ethanol vehicle control usually
coincide with periods of maximum speed and minimum angle changes. (C) Average speeds of PGC movement over the entire imaging period or during run phases. (D) Fraction of
time, (E) average duration, and (F) frequency of PGC run phases or elongatedmorphological states in ethanol- or cyclopamine-treated embryos. Data in panels C–F are the averages of
35 ethanol-treated and 45 cyclopamine-treated PGCs, and error bars represent the standard error of the mean. (G) Chemotaxis of EGFP-expressing PGCs (green) toward transplanted
Sdf1a-expressing cells (red) in ethanol- or cyclopamine-treated embryos. Scale bar: 50 μm.
349J.K. Mich et al. / Developmental Biology 328 (2009) 342–354although the morphant phenotypes were generally less severe than
those of smuhi1640 mutants (Supplementary Fig. 3). The smo MO may
therefore be limited by incomplete efﬁcacy or slow kinetics of action.Fig. 2. Cyclopamine targets both PGCs and somatic cells to effect PGC mislocalization. (
cyclopamine action on PGCs and somatic tissues. Donor embryos were injected at the one-c
dextran to label all donor cells, and one to three PGCs were transplanted from shield-stage (
treated with 100 μM cyclopamine or an ethanol vehicle control prior to transplantation, and
embryos were then scored at 24 hpf for their localization to the presumptive gonad site. (B–
ﬂuorescence images of representative host embryos resulting from the following donor/ho
donor and host; (D) cyclopamine-treated donor and ethanol-treated host; and (E) ethanol-
scoring at least 100 transplanted PGCs for each donor/host condition per experiment. Data
standard error of the mean. (G–L) Distribution of sdf1a transcripts in ethanol- (G–I) and cyclo
shield (G and J), 3-somite (H and K), and 15-somite (I and L) stages are shown. Scale bars:It is also possible that early stage embryos contain maternally
derived Smo protein, which would be unaffected by these antisense
oligonucleotides.A) Schematic representation of the transplantation procedure used to differentiate
ell stage with EGFP-nanos1-3′UTR mRNA to selectively label PGCs and Alexa Fluor 594-
6 hpf) donors into unlabeled sphere-stage (4 hpf) hosts. Donor and host embryos were
cultured until 24 hpf in cyclopamine-free medium. EGFP-expressing PGCs in the host
E) Bright-ﬁeld images, (B′–E′) EGFP ﬂuorescence images, and (B″–E″) Alexa Fluor 594
st treatment regimens: (B) ethanol-treated donor and host; (C) cyclopamine-treated
treated donor and cyclopamine-treated host. (F) Quantiﬁcation of PGC mislocalization,
represent the average of three or more experiments, with error bars representing the
pamine-treated (J–L) embryos from gastrulation to mid-somitogenesis. Embryos at the
200 μm.
Fig. 5. PGC migration is not perturbed in zebraﬁsh embryos lacking maternal and
zygotic Smo but remains cyclopamine-sensitive. (A) Phenotypic distribution of progeny
obtained from mating a chimeric female bearing smuhi1640 ova and either a smuhi160/+
male or a chimera bearing smuhi1640 sperm. (B, C) MZsmuhi1640 embryo treated with
either ethanol or cyclopamine from the one-cell stage to 24 hpf and then stained for
vasa expression. Scale bar: 200 μm.
Fig. 4. Cyclopamine does not disrupt the subcellular organization ormaturation of PGCs.
(A, B) PGC-speciﬁc expression of nanos1, a maternally derived determinant of PGC
speciﬁcation, in ethanol- or cyclopamine-treated embryos. (C, D) Expression of Vasa
protein, which is translated speciﬁcally in PGCs after 4 hpf. (E, F) Perinuclear granules
containing Vasa-dsRedex protein (red) in EGFP-expressing PGCs (green). (G, H) PGC-
speciﬁc expression of ziwi, which is transcribed in PGCs between 24 and 48 hpf. (I, J)
Confocal immunoﬂuorescence imaging of α-tubulin (red) and farnesylated EGFP
(green) in the PGCs of Tg(kop:EGFP-F-nanos1–3′UTR) embryos. Developmental stages:
A–F, 24 hpf; G–H, 48 hpf; I–J, 6 hpf. Scale bars: A–D and G, H, 100 μm; E–F, 20 μm; I, J,
10 μm.
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PGC migration, we depleted both maternal and zygotic smo in
embryos using the germline transplantation technique (Ciruna et al.,
2002). We used progeny resulting from smuhi1640/+ intercrosses as
germline donors, since this allele is the most complete loss of Smo
function of the existing smu alleles (Chen et al., 2001). From our
transplanted embryos, we isolated one adult chimeric female
zebraﬁsh that carried smuhi1640 ova and four chimeric males that
carried smuhi1640 sperm. Crossing the female to any of the four males
resulted in 100% of the progeny exhibiting U-shaped somites, ventralbody curvature, circulation defects, and other smu mutant pheno-
types, (Fig. 5A), thus conﬁrming that these adult zebraﬁsh contain
germline exclusively derived from smuhi1640 progenitor cells.
Progeny resulting from crossing the chimeric adults lack both
maternal and zygotic smo (MZsmuhi1640), providing the appropriate
genetic background for assessing a requirement for Smo in zebraﬁsh
PGC development. We did not observe PGC mislocalization in
MZsmuhi1640 embryos; moreover, PGC migration defects could be
induced in these mutants upon exposure to cyclopamine (Figs. 5B, C).
These results were further conﬁrmed using independently generated
chimeric adults containing ova or sperm homozygous for the smub577
allele (Varga et al., 2001) (Supplementary Fig. 4). Thus, the ability of
cyclopamine to perturb PGC migration is not due to Smo inhibition,
and Smo-dependent processes such as Hh signaling are dispensible
for proper PGC migration in zebraﬁsh.
Cyclopamine-induced PGC mislocalization can be partially rescued by
depleting E-cadherin levels
Since cyclopamine does not perturb PGC migration by inhibiting
Smo, we sought to determine the mechanism of action of this
teratogen. The speciﬁc perturbation of PGC speed by cyclopamine
351J.K. Mich et al. / Developmental Biology 328 (2009) 342–354rather than chemotaxis or maturation directed us to analyze
functional components of the cell motility apparatus. We ﬁrst
investigated whether cyclopamine perturbs actin or tubulin polymers
in PGCs, as these cytoskeletal structures have been shown to be
necessary for zebraﬁsh PGC migration (Blaser et al., 2006). Global
changes in actin (data not shown) or tubulin (Figs. 4I, J) cytoskeletal
architecture were not observed in cyclopamine-treated PGCs at 6 hpf,
during which these cells are normally undergoing extensive migra-
tion. These results indicate that cyclopamine does not grossly disrupt
the PGC cytoskeleton.
Other regulators of zebraﬁsh PGC migration include cell adhesion
molecules such as E-cadherin, in analogy to other migratory cell
populations (Nakagawa and Takeichi, 1998; Niewiadomska et al.,
1999; Nishimura et al., 1999). E-cadherin is downregulated during the
onset of PGC motility, presumably to achieve cell adhesive properties
with the surrounding somatic tissues that are appropriate for
migration (Blaser et al., 2005). We therefore assessed whether
cyclopamine inhibits PGC migration by altering cell adhesive interac-
tions in the zebraﬁsh embryo. Our time-lapsemovies of PGCmigration
revealed that cell–cell contacts between PGCs persisted for longer
durations in embryos exposed to cyclopamine than those treated with
an ethanol vehicle control alone (Figs. 6A, B). In principle, this
increased contact time could either cause or reﬂect the decreased
speed of cyclopamine-treated PGCs. In support of the former option,
we observed that reduction of E-cadherin expression by MO knock-Fig. 6. Cyclopamine perturbs PGC migration in part through dysregulated cell adhesion. (A) T
F-nanos1-3′UTR) embryos. (B) Average duration of each PGC–PGC contact for both treatme
PGCs, and error bars represent the standard error of the mean. (C, D) Distribution of vasa-pos
at the one-cell stage and then treated with 50 μM cyclopamine until 24 hpf. Scale bar: 200 μm
E-cadherin MO and treated with cyclopamine or an ethanol vehicle control. At least 500 P
expression in embryos treated with ethanol or cyclopamine from the one-cell stage to the
loading control is shown. (G, H) Confocal immunoﬂuorescence imaging of E-cadherin expredown partially rescued the cyclopamine-induced PGC defect when
teratogen and E-cadherin MO doses were appropriately matched. For
example, we achieved a partial rescue of PGC migration in embryos
treated with 50 μM cyclopamine upon the microjection of E-cadherin
MOat a dose of 300 pg/embryo (Figs. 6C–E and Supplementary Fig. 5).
PGC migration in embryos microinjected with the E-cadherin MO at
doses greater than 500 pg/embryo could not be analyzed since these
conditions induced gastrulation defects analogous to those observed
in half-baked mutants, which lack zygotic E-cadherin (Kane et al.,
2005) (data not shown). In contrast, a ﬁve-base mismatch control MO
did not reduce E-cadherin expression levels and did not mitigate
cyclopamine-induced PGC mislocalization (Supplementary Fig. 5).
During the course of our time-lapse experiments, we also observed
that PGCs in cyclopamine-treated embryos occasionally fragment
during their migration, perhaps reﬂecting an uncoupling of transloca-
tion and adhesion disassembly during cell migration (Supplementary
Movie 8). Collectively, these observations suggest that cell adhesive
forces are dysregulated upon cyclopamine exposure. We did not
observe, however, cyclopamine-dependent changes in E-cadherin
expression levels or subcellular localization, as determined bywestern
blot analysis and whole-mount immunoﬂuorescence (Figs. 6F–H).
Thus, while the abnormal cell adhesion is likely to be at least one
contributing mechanism by which cyclopamine perturbs PGC migra-
tion, this teratogen appears to affect cell adhesion molecules other
than E-cadherin. Alternatively, cyclopamine might modify theime-lapse imaging of PGC interactions in ethanol- or cyclopamine-treated Tg(kop:EGFP-
nt conditions. Data are the averages of 35 ethanol-treated and 45 cyclopamine-treated
itive PGCs in embryos injected with either water or an E-cadherinMO (300 pg/embryo)
. (E) Quantiﬁcation of PGCmislocalization in embryos injectedwith varying doses of the
GCs were scored for each experimental condition. (F) Western analysis of E-cadherin
sphere stage (6 hpf). Quantiﬁcation of E-cadherin expression normalized to a β-actin
ssion and localization in identically treated embryos. Scale bars: A, 20 μm; C, D, 200 μm.
352 J.K. Mich et al. / Developmental Biology 328 (2009) 342–354intrinsic activity of E-cadherin proteins, perhaps increasing their
adhesive properties.
Discussion
The molecular mechanisms that regulate PGC speciﬁcation,
migration, and differentiation are remarkably conserved across
species. For example, nanos and vasa play critical roles in PGC
speciﬁcation in Drosophila and zebraﬁsh (Hay et al., 1988; Koprunner
et al., 2001; Wang and Lehmann, 1991; Yoon et al., 1997). Mammalian
orthologs of nanos and vasa are also required for germ cell
development (Fujiwara et al., 1994; Tsuda et al., 2003), although
these progenitor cells are speciﬁed by inductive signals such as the
bone morphogenetic proteins (Lawson et al., 1999; Ying et al., 2000;
Ying and Zhao, 2001). Orthologs of the dnd gene promote PGC
migration and survival in zebraﬁsh and mice (Weidinger et al., 2003;
Youngren et al., 2005), and HMG-CoAR is required for PGC chemotaxis
in fruitﬂies and zebraﬁsh (Thorpe et al., 2004; Van Doren et al., 1998).
In addition, members of the piwi family of RNA-interactors are critical
regulators of germline maintenance in fruitﬂies, zebraﬁsh, and mice
(Cox et al., 1998; Deng and Lin, 2002; Houwing et al., 2007;
Kuramochi-Miyagawa et al., 2004).
Previous studies have implicated Hh signaling proteins in the
regulation of Drosophila PGCmigration (Deshpande and Schedl, 2005;
Deshpande et al., 2007, 2001). It has been reported that fruitﬂy
embryos lacking maternal expression of the Hh pathway regulators
ptc, smo, fu, or pka exhibit mislocalized PGCs and that germ cells can
be recruited to sites of ectopic hh expression (Deshpande et al., 2001).
More recent ﬁndings have suggested that HMG-CoAR and its down-
stream target Gγ1 promote Hh protein secretion and movement
(Deshpande et al., 2009; Deshpande and Schedl, 2005), thereby
supporting a model in which somatic gonadal precursor cells produce
Hh protein to attract migratory PGCs to the presumptive gonad site.
Given the molecular similarities of PGC development across species,
we sought to determine whether Hh signaling proteins are required
for zebraﬁsh PGC development, using both pharmacological and
genetic perturbations of the Hh pathway. In this report, we
demonstrate that cyclopamine, a small-molecule inhibitor of Smo,
perturbs PGC motility in the zebraﬁsh embryo, but Smo itself is
dispensable for PGC homing to the presumptive gonad. Zygotic Smo
activity also does not appear to be required for zebraﬁsh PGC
maturation or formation of the gonad itself, as both male and female
zebraﬁsh with reproductive organs derived from smu mutant germ-
line tissues are fertile.
These observations raise the possibility that PGC migration has
mechanistically diverged between invertebrates and vertebrates. Hh
signaling mechanisms in Drosophila, zebraﬁsh, and mice may also
differ, since invertebrate- and vertebrate-speciﬁc pathway compo-
nents have been identiﬁed (Varjosalo et al., 2006). Alternatively, the
PGC migration defects previously attributed to altered Hh signaling in
Drosophila could be due to coincident perturbations to other cellular
processes. In support of this latter possibility, independent studies by
Renault et al. (2009) argue against the involvement of Hh or its
downstream effectors in Drosophila PGC migration. As described in
the accompanying paper, Renault et al. (2009) did not observe PGC
migration defects in embryos lacking maternal smo or ttv function,
nor did they detect abnormal germ cell development when dominant
negative or constitutively active versions of Hh signaling components
were selectively expressed in these cells. They further observed that
germ line clones mutant for ptc or pka failed to complete oogenesis,
precluding any analysis of PGC migration in these genetic back-
grounds, and they found that the chemoattractant activity of HMG-
CoAR-expressing cells was Hh-independent, obviating any require-
ment for Hh signaling in directed PGC migration. Taken together, our
results and those of Renault et al. (2009) call into question any role for
Hh signaling in PGC migration.Our observation that cyclopamine acts independently of Smo to
disrupt zebraﬁsh PGC migration is also surprising, as this small
molecule has been used extensively to study Hh pathway-dependent
patterning in this model organism. Since no other Smo homolog has
been identiﬁed in zebraﬁsh, cyclopamine most likely acts indepen-
dently of the Hh pathway to induce PGC mislocalization. Our studies
indicate that cyclopamine acts during the earliest stages of PGC
migration (3 to 6 hpf), which is characterized by the cell-autonomous
downregulation of E-cadherin levels (Blaser et al., 2005). In particular,
our observations suggest that cyclopamine-induced PGC mislocaliza-
tion is due at least in part to altered cell adhesive properties. PGCs in
embryos treated with cyclopamine maintain cell–cell contacts for
unusually long durations, and although our analyses focused on PGC–
PGC interactions, it is likely that adhesive interactions between PGCs
and somatic cells are similarly perturbed by cyclopamine. Indeed, our
observation that cyclopamine acts primarily through the soma to
disrupt PGC migration suggests that increased cellular adhesion
between PGCs and somatic cells and/or within the soma may be the
dominant cause of cyclopamine-induced PGC mislocalization. Con-
sistent with this model, PGC migration to the presumptive gonad site
in cyclopamine-treated embryos can be partially rescued by globally
reducing E-cadherin expression. Dysregulated PGC-soma adhesion
could also explain why cyclopamine reduces the frequency of run
phases during PGC movement and occasionally causes PGC fragmen-
tation. These ﬁndings highlight the importance of properly regulated
cell adhesion to permit cell migration, as has been demonstrated for
border cells (Niewiadomska et al., 1999) and melanocytes (Nakagawa
and Takeichi, 1998; Nishimura et al., 1999), among others.
How cyclopamine might dysregulate cell adhesive properties
remains unclear. The timing of cyclopamine action also coincides
with the onset of zygotic transcription in zebraﬁsh embryos; however,
microarray analyses do not reveal any signiﬁcant changes in the
expression of cell adhesion regulators upon cyclopamine treatment
(data not shown). Cyclopamine might therefore perturb the activity of
cell adhesion molecules in a post-transcriptional manner. Regardless
of the precise mechanism of action, our observations urge caution in
the interpretation of in vivo data obtained from cyclopamine-treated
zebraﬁsh embryos. For example, the effects of cyclopamine on early-
stage embryos that have been ascribed to maternal Smo inhibition
(Chen et al., 2001) may warrant genetic conﬁrmation in MZsmuhi1640
zebraﬁsh. Recent reports that cyclopamine blocks anchorage-depen-
dent growth of breast cancer cells in a Smo-independent manner
(Zhang et al., 2008) also raises the possibility that the cyclopamine-
induced PGC defects we observe in zebraﬁsh embryos may have
implications for cellular behavior in other species.
Our observations shed some light on the mechanisms by which
PGCs migrate. Cyclopamine-treated PGCs exhibit both a slower speed
during run phases and a reduction in the fraction of time spent in
these states, which together signiﬁcantly abrogate cell migration. This
motility defect contrasts phenotypes associated with loss of the
chemoattractant sdf1a or its receptor cxcr4b, in which PGCs are
observed less frequently in the run phase but migrate a normal speeds
(Reichman-Fried et al., 2004). In addition, cyclopamine-treated PGCs
demonstrate that cell polarization and translocation, which are
intimately connected in the native condition, can be uncoupled.
Other features of PGC migration remain intact in cyclopamine-
treated embryos. First, the fraction of time these cells exhibit an
elongated morphology is unchanged since increased duration times
compensate for reduced frequencies. This observation may reﬂect a
fundamental property of PGCs: they are able to polarize and extend
cellular protrusions even when motility is impaired. Indeed, random
polarizations and protrusions are observed in PGCs prior to their
acquisition of motility (Blaser et al., 2005). Second, PGCs in
cyclopamine-treated embryos have run phase durations that resemble
those of wildtype zebraﬁsh, despite being inhibited in their frequency
and speed, suggesting that this cellular behaviormight be subject to an
353J.K. Mich et al. / Developmental Biology 328 (2009) 342–354intrinsic clock mechanism. Elucidation of the molecular changes that
occur upon cyclopamine exposurewill provide further insights into the
regulatory mechanisms of PGC migration.
Acknowledgments
We thank W. Talbot for syutbx392 zebraﬁsh; R. Karlstrom for dtrts269
zebraﬁsh; H. Knaut for anti-Vasa antibody; J. Marrs for anti-E-cadherin
antibody; and B. Ciruna, I. Woods, M. Voas, M. Strasser, and B.
Boldijapour for their technical assistance. This work was supported by
an American Cancer Society Research Scholar Grant (RSG-08-041-01-
DDC) to J.K.C., March of Dimes (1-FY2005-121) and National Institutes
of Health (R01 HL069594) grants to D. Y., a California Institute for
Regenerative Medicine Scholar Award (T1-0001) to J.K.M., and
funding from the New York University Graduate Training Program in
Developmental Genetics (NIH T32 HD007520) to N.A.T.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ydbio.2009.01.036.
References
Babb, S.G., Marrs, J.A., 2004. E-cadherin regulates cell movements and tissue formation
in early zebraﬁsh embryos. Dev. Dyn. 230, 263–277.
Blaser, H., Eisenbeiss, S., Neumann, M., Reichman-Fried, M., Thisse, B., Thisse, C., Raz, E.,
2005. Transition from non-motile behaviour to directed migration during early PGC
development in zebraﬁsh. J. Cell Sci. 118, 4027–4038.
Blaser, H., Reichman-Fried, M., Castanon, I., Dumstrei, K., Marlow, F.L., Kawakami, K.,
Solnica-Krezel, L., Heisenberg, C.P., Raz, E., 2006. Migration of zebraﬁsh primordial
germ cells: a role for myosin contraction and cytoplasmic ﬂow. Dev. Cell 11,
613–627.
Boldajipour, B., Mahabaleshwar, H., Kardash, E., Reichman-Fried, M., Blaser, H., Minina,
S., Wilson, D., Xu, Q., Raz, E., 2008. Control of chemokine-guided cell migration by
ligand sequestration. Cell 132, 463–473.
Boyle, M., Bonini, N., DiNardo, S., 1997. Expression and function of clift in the
development of somatic gonadal precursors within the Drosophila mesoderm.
Development 124, 971–982.
Chen, W., Burgess, S., Hopkins, N., 2001. Analysis of the zebraﬁsh smoothened mutant
reveals conserved and divergent functions of hedgehog activity. Development 128,
2385–2396.
Chen, J.K., Taipale, J., Cooper, M.K., Beachy, P.A., 2002a. Inhibition of Hedgehog signaling
by direct binding of cyclopamine to Smoothened. Genes Dev. 16, 2743–2748.
Chen, J.K., Taipale, J., Young, K.E., Maiti, T., Beachy, P.A., 2002b. Small molecule
modulation of Smoothened activity. Proc. Natl. Acad. Sci. U. S. A. 99, 14071–14076.
Ciruna, B., Weidinger, G., Knaut, H., Thisse, B., Thisse, C., Raz, E., Schier, A.F., 2002.
Production of maternal-zygotic mutant zebraﬁsh by germ-line replacement. Proc.
Natl. Acad. Sci. U. S. A. 99, 14919–14924.
Cox, D.N., Chao, A., Baker, J., Chang, L., Qiao, D., Lin, H., 1998. A novel class of
evolutionarily conserved genes deﬁned by piwi are essential for stem cell self-
renewal. Genes Dev. 12, 3715–3727.
Deng, W., Lin, H., 2002. miwi, a murine homolog of piwi, encodes a cytoplasmic protein
essential for spermatogenesis. Dev. Cell 2, 819–830.
Deshpande, G., Schedl, P., 2005. HMGCoA reductase potentiates hedgehog signaling in
Drosophila melanogaster. Dev. Cell 9, 629–638.
Deshpande, G., Swanhart, L., Chiang, P., Schedl, P., 2001. Hedgehog signaling in germ cell
migration. Cell 106, 759–769.
Deshpande, G., Sethi, N., Schedl, P., 2007. toutvelu, a regulator of heparan sulfate
proteoglycan biosynthesis, controls guidance cues for germ-cell migration.
Genetics 176, 905–912.
Deshpande, G., Godishala, A., Schedl, P., 2009. Ggamma1, a downstream target for the
hmgcr-isoprenoid biosynthetic pathway, is required for releasing the Hedgehog
ligand and directing germ cell migration. PLoS Genet. 5, e1000333.
Doitsidou, M., Reichman-Fried, M., Stebler, J., Koprunner, M., Dorries, J., Meyer, D.,
Esguerra, C.V., Leung, T., Raz, E., 2002. Guidance of primordial germ cell migration
by the chemokine SDF-1. Cell 111, 647–659.
Dumstrei, K., Mennecke, R., Raz, E., 2004. Signaling pathways controlling primordial
germ cell migration in zebraﬁsh. J. Cell Sci. 117, 4787–4795.
Fujiwara, Y., Komiya, T., Kawabata, H., Sato, M., Fujimoto, H., Furusawa, M., Noce, T.,
1994. Isolation of a DEAD-family protein gene that encodes a murine homolog of
Drosophila vasa and its speciﬁc expression in germ cell lineage. Proc. Natl. Acad.
Sci. U. S. A. 91, 12258–12262.
Hauptmann, G., Gerster, T., 1994. Two-color whole-mount in situ hybridization to
vertebrate and Drosophila embryos. Trends Genet. 10, 266.
Hay, B., Jan, L.Y., Jan, Y.N., 1988. A protein component of Drosophila polar granules is
encoded by vasa and has extensive sequence similarity to ATP-dependent helicases.
Cell. 55, 577–587.Houwing, S., Kamminga, L.M., Berezikov, E., Cronembold, D., Girard, A., van den Elst,
H., Filippov, D.V., Blaser, H., Raz, E., Moens, C.B., Plasterk, R.H., Hannon, G.J.,
Draper, B.W., Ketting, R.F., 2007. A role for Piwi and piRNAs in germ cell
maintenance and transposon silencing in zebraﬁsh. Cell 129, 69–82.
Ingham, P.W., McMahon, A.P., 2001. Hedgehog signaling in animal development:
paradigms and principles. Genes Dev. 15, 3059–3087.
Jowett, T., Lettice, L., 1994. Whole-mount in situ hybridizations on zebraﬁsh embryos
using a mixture of digoxigenin- and ﬂuorescein-labelled probes. Trends Genet. 10,
73–74.
Kane, D.A., McFarland, K.N., Warga, R.M., 2005. Mutations in half baked/E-cadherin
block cell behaviors that are necessary for teleost epiboly. Development 132,
1105–1116.
Karlstrom, R.O., Talbot, W.S., Schier, A.F., 1999. Comparative synteny cloning of zebraﬁsh
you-too: mutations in the Hedgehog target gli2 affect ventral forebrain patterning.
Genes Dev. 13, 388–393.
Karlstrom, R.O., Tyurina, O.V., Kawakami, A., Nishioka, N., Talbot, W.S., Sasaki, H., Schier,
A.F., 2003. Genetic analysis of zebraﬁsh gli1 and gli2 reveals divergent requirements
for gli genes in vertebrate development. Development 130, 1549–1564.
Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., Schilling, T.F., 1995. Stages of
embryonic development of the zebraﬁsh. Dev. Dyn. 203, 253–310.
Knaut, H., Pelegri, F., Bohmann, K., Schwarz, H., Nusslein-Volhard, C., 2000. Zebraﬁsh
vasa RNA but not its protein is a component of the germ plasm and segregates
asymmetrically before germline speciﬁcation. J. Cell Biol. 149, 875–888.
Knaut, H., Werz, C., Geisler, R., Nusslein-Volhard, C., 2003. A zebraﬁsh homologue of the
chemokine receptor Cxcr4 is a germ-cell guidance receptor. Nature 421, 279–282.
Koprunner, M., Thisse, C., Thisse, B., Raz, E., 2001. A zebraﬁsh nanos-related gene is
essential for the development of primordial germ cells. Genes Dev. 15, 2877–2885.
Kunwar, P.S., Siekhaus, D.E., Lehmann, R., 2006. In vivo migration: a germ cell
perspective. Annu. Rev. Cell Dev. Biol. 22, 237–265.
Kuramochi-Miyagawa, S., Kimura, T., Ijiri, T.W., Isobe, T., Asada, N., Fujita, Y., Ikawa, M.,
Iwai, N., Okabe, M., Deng, W., Lin, H., Matsuda, Y., Nakano, T., 2004. Mili, a
mammalian member of piwi family gene, is essential for spermatogenesis.
Development 131, 839–849.
Lawson, K.A., Dunn, N.R., Roelen, B.A., Zeinstra, L.M., Davis, A.M., Wright, C.V., Korving, J.
P., Hogan, B.L., 1999. Bmp4 is required for the generation of primordial germ cells in
the mouse embryo. Genes Dev. 13, 424–436.
Lehmann, R., Nusslein-Volhard, C., 1986. Abdominal segmentation, pole cell formation,
and embryonic polarity require the localized activity of oskar, a maternal gene in
Drosophila. Cell 47, 141–152.
Ma, Y., Erkner, A., Gong, R., Yao, S., Taipale, J., Basler, K., Beachy, P.A., 2002. Hedgehog-
mediated patterning of the mammalian embryo requires transporter-like function
of dispatched. Cell 111, 63–75.
Macdonald, R., 1999. Zebraﬁsh immunohistochemistry. Methods Mol. Biol. 127, 77–88.
Nakagawa, S., Takeichi, M., 1998. Neural crest emigration from the neural tube depends
on regulated cadherin expression. Development 125, 2963–2971.
Nakano, Y., Kim, H.R., Kawakami, A., Roy, S., Schier, A.F., Ingham, P.W., 2004. Inactivation
of dispatched 1 by the chameleon mutation disrupts Hedgehog signalling in the
zebraﬁsh embryo. Dev. Biol. 269, 381–392.
Niewiadomska, P., Godt, D., Tepass, U., 1999. DE-Cadherin is required for intercellular
motility during Drosophila oogenesis. J. Cell Biol. 144, 533–547.
Nishimura, E.K., Yoshida, H., Kunisada, T., Nishikawa, S.I., 1999. Regulation of E- and P-
cadherin expression correlated with melanocyte migration and diversiﬁcation. Dev.
Biol. 215, 155–166.
Nusslein-Volhard, C., Dahm, R. (Eds.), 2002. Zebraﬁsh: a Practical Approach. Oxford
University Press, New York City.
Olsen, L.C., Aasland, R., Fjose, A., 1997. A vasa-like gene in zebraﬁsh identiﬁes putative
primordial germ cells. Mech. Dev. 66, 95–105.
Raz, E., 2003. Primordial germ-cell development: the zebraﬁsh perspective. Nat. Rev.
Genet. 4, 690–700.
Reichman-Fried, M., Minina, S., Raz, E., 2004. Autonomous modes of behavior in
primordial germ cell migration. Dev. Cell 6, 589–596.
Renault, A.D., Sigal, Y.J., Morris, A.J., Lehmann, R., 2004. Soma-germ line competition for
lipid phosphate uptake regulates germ cell migration and survival. Science 305,
1963–1966.
Renault, A.D., Ricardo, S., Kunwar, P.S., Santos, A., Starz-Gainao, M., Stein, J.A., Lehmann,
R., 2009. Hedgehog does not guide migrating Drosophila germ cells. Dev. Biol.
355–362.
Robu, M.E., Larson, J.D., Nasevicius, A., Beiraghi, S., Brenner, C., Farber, S.A., Ekker, S.C.,
2007. p53 activation by knockdown technologies. PLoS Genet. 3, e78.
Santos, A.C., Lehmann, R., 2004. Isoprenoids control germ cell migration downstream of
HMGCoA reductase. Dev. Cell 6, 283–293.
Sasaki, H., Hui, C., Nakafuku, M., Kondoh, H., 1997. A binding site for Gli proteins is
essential for HNF-3beta ﬂoor plate enhancer activity in transgenics and can respond
to Shh in vitro. Development 124, 1313–1322.
Schauerte, H.E., van Eeden, F.J., Fricke, C., Odenthal, J., Strahle, U., Haffter, P., 1998. Sonic
hedgehog is not required for the induction of medial ﬂoor plate cells in the
zebraﬁsh. Development 125, 2983–2993.
Shimizu, T., Yabe, T., Muraoka, O., Yonemura, S., Aramaki, S., Hatta, K., Bae, Y.K., Nojima,
H., Hibi, M., 2005. E-cadherin is required for gastrulation cell movements in
zebraﬁsh. Mech. Dev. 122, 747–763.
Strasser, M.J., Mackenzie, N.C., Dumstrei, K., Nakkrasae, L.I., Stebler, J., Raz, E., 2008.
Control over the morphology and segregation of Zebraﬁsh germ cell granules
during embryonic development. BMC Dev. Biol. 8, 58.
Taipale, J., Chen, J.K., Cooper, M.K., Wang, B., Mann, R.K., Milenkovic, L., Scott, M.P.,
Beachy, P.A., 2000. Effects of oncogenic mutations in Smoothened and Patched can
be reversed by cyclopamine. Nature 406, 1005–1009.
354 J.K. Mich et al. / Developmental Biology 328 (2009) 342–354Thomas, N.A., Koudijs, M., van Eeden, F.J., Joyner, A.L., Yelon, D., 2008. Hedgehog
signaling plays a cell-autonomous role in maximizing cardiac developmental
potential. Development 135, 3789–3799.
Thorpe, J.L., Doitsidou, M., Ho, S.Y., Raz, E., Farber, S.A., 2004. Germ cell migration in
zebraﬁsh is dependent on HMGCoA reductase activity and prenylation. Dev. Cell 6,
295–302.
Tsuda, M., Sasaoka, Y., Kiso, M., Abe, K., Haraguchi, S., Kobayashi, S., Saga, Y., 2003.
Conserved role of nanos proteins in germ cell development. Science 301,
1239–1241.
Van Doren, M., Broihier, H.T., Moore, L.A., Lehmann, R., 1998. HMG-CoA reductase guides
migrating primordial germ cells. Nature 396, 466–469.
Varga, Z.M., Amores, A., Lewis, K.E., Yan, Y.L., Postlethwait, J.H., Eisen, J.S., Westerﬁeld,
M., 2001. Zebraﬁsh smoothened functions in ventral neural tube speciﬁcation and
axon tract formation. Development 128, 3497–3509.
Varjosalo, M., Li, S.P., Taipale, J., 2006. Divergence of hedgehog signal transduction
mechanism between Drosophila and mammals. Dev. Cell 10, 177–186.
Wang, C., Lehmann, R., 1991. Nanos is the localized posterior determinant in Drosophila.
Cell 66, 637–647.
Warrior, R., 1994. Primordial germ cell migration and the assembly of the Drosophila
embryonic gonad. Dev. Biol. 166, 180–194.
Weidinger, G., Wolke, U., Koprunner, M., Klinger, M., Raz, E., 1999. Identiﬁcation of
tissues and patterning events required for distinct steps in early migration of
zebraﬁsh primordial germ cells. Development 126, 5295–5307.Weidinger, G., Stebler, J., Slanchev, K., Dumstrei, K., Wise, C., Lovell-Badge, R., Thisse, C.,
Thisse, B., Raz, E., 2003. dead end, a novel vertebrate germ plasm component, is
required for zebraﬁsh primordial germ cell migration and survival. Curr. Biol. 13,
1429–1434.
Westerﬁeld, M., 1995. The Zebraﬁsh Book. University of Oregan Press, Oregon.
Wolff, C., Roy, S., Ingham, P.W., 2003. Multiple muscle cell identities induced by distinct
levels and timing of hedgehog activity in the zebraﬁsh embryo. Curr. Biol. 13,
1169–1181.
Ying, Y., Zhao, G.Q., 2001. Cooperation of endoderm-derived BMP2 and extraembryonic
ectoderm-derived BMP4 in primordial germ cell generation in the mouse. Dev. Biol.
232, 484–492.
Ying, Y., Liu, X.M.,Marble, A., Lawson, K.A., Zhao, G.Q., 2000. Requirement of Bmp8b for the
generation of primordial germ cells in the mouse. Mol. Endocrinol. 14, 1053–1063.
Yoon, C., Kawakami, K., Hopkins, N., 1997. Zebraﬁsh vasa homologue RNA is localized to
the cleavage planes of 2- and 4-cell-stage embryos and is expressed in the
primordial germ cells. Development 124, 3157–3165.
Youngren, K.K., Coveney, D., Peng, X., Bhattacharya, C., Schmidt, L.S., Nickerson, M.L.,
Lamb, B.T., Deng, J.M., Behringer, R.R., Capel, B., Rubin, E.M., Nadeau, J.H., Matin, A.,
2005. The Ter mutation in the dead end gene causes germ cell loss and testicular
germ cell tumours. Nature 435, 360–364.
Zhang, X., Harrington, N., Moraes, R.C., Wu, M.F., Hilsenbeck, S.G., Lewis, M.T., 2008.
Cyclopamine inhibition of human breast cancer cell growth independent of
Smoothened (Smo). Breast Cancer Res. Treat doi:10.1007/s10549-008-0093-3.
